Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicam

International Journal of Pharmaceutics

Volumn 381, Issue 2, 2009, Pages 153-159

  Ambrus, R ^a,b   Kocbek, P ^a   Kristl, J ^a   Sibanc R ^a   Rajko R ^b   Szabo Revesz P ^b  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Emulsion diffusion method; High pressure homogenization; Meloxicam; Nanosuspension; Sonication; X ray powder diffraction

Indexed keywords

MELOXICAM; NANOPARTICLE; POLOXAMER; POLYSORBATE 80; POVIDONE;

ARTICLE; DIFFUSION; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; NANOEMULSION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; ULTRASOUND;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; DRUG COMPOUNDING; EMULSIONS; EXCIPIENTS; FREEZE DRYING; ISOELECTRIC POINT; MICROSCOPY, ELECTRON, SCANNING; MODELS, STATISTICAL; NANOPARTICLES; PARTICLE SIZE; POWDER DIFFRACTION; POWDERS; SOLUBILITY; SOLVENTS; SONICATION; SUSPENSIONS; THIAZINES; THIAZOLES;

EID: 70349275191     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.07.009     Document Type: Article

References (28)

1. Bashiri-Shahroodi A., Nassab P.R., Szabó-Révész P., and Rajkó R. Preparation of solid dispersion by dropping method to improve dissolution rate of meloxicam as poorly water-soluble drug. Drug Dev. Ind. Pharm. 34 (2008) 781-788
2. Borgen O.S., and Knowalski B.R. An extension of the multivariate component-resolution method to three components. Anal. Chim. Acta 174 (1985) 1-26
3. Borgen O.S., Davidsen N., Mingyang Z., and Oyen O. The multivariate N-component resolution problem with minimum assumptions. Microchim. Acta II (1986) 63-73
4. Debuigne F., Cuisenaire J., Jeunieau L., Masereel B., and Nagy J.B. Synthesis of nimesulid nanoparticles in the microemulsion epikuron/isopropyl myristate/water/n-butanol (or isopropanol). J. Colloid. Interface Sci. 243 (2001) 90-101
5. de Juan A., and Tauler R. Multivariate curve resolution (MCR) from 2000: progress in concepts and applications. Crit. Rev. Anal. Chem. 36 (2006) 163-176
6. Del Tacca M., Colucci R., Fornai M., and Blandizzi C. Efficacy and tolerability of meloxicam, a COX-2 preferential nonsteroidal antiinflamatory drug: a review. Clin. Drug Invest. 22 (2002) 799-818
7. Fahmy M. Ca-alginate beads loaded with meloxicam: effect of alginate chemical composition on the properties of the beads and ulcerogenicity of the drug. J. Drug Del. Sci. Technol. 16 (2006) 183-189
8. Fiala J. Powder diffraction analysis of three-component sample. Anal. Chem. 52 (1980) 1300-1304
9. Goldman A.P., Williams C.S., Sheng H., Lamps L.W., Williams V.P., Pairet M., Morrow J.D., and DuBois R.N. Meloxicam inhibits the growth of colorectal cancer cells. Carcinogenesis 19 (1998) 2195-2199
10. Hanft G., Türck D., Scheuerer S., and Sigmund R. Meloxicam oral suspension: a treatment alternative to solid meloxicam formulations. Inflamm. Res. 50 (2001) S35-S37
11. Hecq J., Deleers M., Fanara D., Vranckx H., and Amighi K. Preparation and characterisation of nanocrystals for solubility and dissolution rate enhancement of nifedipine. Int. J. Pharm. 299 (2005) 167-177
12. Kesisoglon F., Panmai S., and Wu Y. Nanosizing oral formulation development and biopharmaceutical evaluation. Adv. Drug. Dev. Rev. 59 (2007) 631-644
13. Kocbek P., Baumgartner S., and Kristl J. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs. Int. J. Pharm. 312 (2006) 179-186
14. Lawton W.H., and Sylvestre E.A. Self modelling curve resolution. Technometrics 88 (1971) 617-633
15. Leuner C., and Dressmann J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. BioPharm. 54 (2002) 107-112
16. Liang E., Chessec K., and Yazdanin M. Evaulation of an accelerated Caco-2 cell permeability model. J. Pharm. Sci. 89 (2000) 336-345
17. Liversidge G.G., and Conzentino P. Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats. Int. J. Pharm. 125 (1995) 309-313
18. Möschwitzer J., Achleitner G., Pomper H., and Müller R.H. Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology. Eur. J. Pharm. Biopharm. 58 (2004) 615-619
19. Müller R.H., and Akkar A. Encyclopedia of Nanoscience and Nanotechnology (2004), American Scientific Publishers pp. 624-638
20. Patil M.P., and Pandit A.B. A novel technique for making stable nanosuspension. Ultrason. Sonochem. 14 (2007) 519-530
21. Patravale V.B., Date A.A., and Kulkarni R.M. Nanosuspensions: a promising drug delivery strategy. J. Pharm. Pharmacol. 56 (2004) 827-840
22. Peters K., Leitzke S., Diederichs J.E., Borner K., Hahn H., Müller R.H., and Ehlers S. Preparation of clofazamine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in Mycobacterium avium infection. J. Antimicrob. Chem. 45 (2000) 77-83
23. Rabinow B.E. Nanosuspension in drug delivery. Nat. Rev Drug Discov. 3 (2004) 785-796
24. Rajkó R., and István K. Analytical solution for determining feasible regions of self-modeling curve resolution (SMCR) method based on computational geometry. J. Chemom. 19 (2005) 1-16
25. Rajkó R. Natural duality in minimal constrained self modeling curve resolution. J. Chemom. 20 (2006) 164-169
26. Reisi Nassab P., Rajkó R., and Szabó-Révész P. Physicochemical characterization of meloxicam-mannitol binary systems. J. Pharm. Biomed. Anal. 41 (2006) 1191-1197
27. Trotta M., Gallarete M., Pattarino F., and Morel S. Emulsions containing partially water-miscible solvents for the preparation of drug nanosuspensions. J. Control. Release 76 (2001) 119-128
28. Yeo Y., Basaran O.A., and Park K. A new process for making reservoir-type micro capsules using ink-jet technology and interfacial phase separation. J. Control. Release 93 (2003) 161-173